About this trial
The goal of this observational, no-profit, spontaneous, retrospective, monocentric study is to compare surgical and oncologic outcomes in patients affected by gastric cancer before and after the institution of the Tumor Board, a multidisciplinary weekly case discussion. The main question it aims to answer is whether the Textbook Outcome (TO) and Textbook Oncological Outcome (TOO) of patients with non-early, non-metastatic gastric cancer undergoing surgical treatment with curative intent have improved before (from January 2018 to November 2019) and after (from December 2019 onwards) the establishment of the Multidisciplinary Tumor Board (MTB) at Fondazione Policlinico Gemelli (FPG).
Eligibility criteria
Qualifiers
pathology-confirmed diagnosis of gastric adenocarcinoma
age 18 years or older
surgical candidates with curative intent
Disqualifiers
Endoscopic Mucosal Resection (EMR) or Endoscopic Submucosal Dissection (ESD)
previous EMR or ESD (salvage surgery)
histologies other than adenocarcinoma (no squamous cell carcinomas, GISTs, sarcomas, lymphomas, etc)
unsufficient staging (unclear clinical stage at diagnosis)
Trial design
Treatments tested in this trial
- Multidisciplinary Tumor Board
Treatment groups
Sponsors and collaborators
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead sponsor
Società Italiana di Chirurgia Oncologica SICO - ESSO affiliated
Collaborator